These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 4273178)
21. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Chu CY Br J Dermatol; 2005 Feb; 152(2):396-9. PubMed ID: 15727676 [No Abstract] [Full Text] [Related]
22. [Rosacea-like perioral dermatitis]. Petzoldt D Z Haut Geschlechtskr; 1971 Oct; 46(19):590-5. PubMed ID: 4257710 [No Abstract] [Full Text] [Related]
30. [Perioral dermatitis (mechanism of its development and treatment)]. Korolev IuF; Strizhonok VP Vestn Dermatol Venerol; 1977 Oct; (10):43-5. PubMed ID: 595834 [No Abstract] [Full Text] [Related]
31. [Perioral dermatitis and other skin disorders following local application of fluoridated corticosteroids]. Mali JH Ned Tijdschr Geneeskd; 1980 Jan; 124(1):2-7. PubMed ID: 6445510 [No Abstract] [Full Text] [Related]
32. [Perioral dermatitis in the light of the literature]. Starzycki Z Przegl Dermatol; 1984; 71(4):389-94. PubMed ID: 6393222 [No Abstract] [Full Text] [Related]
33. [Perioral dermatitis]. Verburgh-van der Zwan N Ned Tijdschr Geneeskd; 1975 May; 119(19):742-7. PubMed ID: 124823 [No Abstract] [Full Text] [Related]
36. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption. Chu CY J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975 [TBL] [Abstract][Full Text] [Related]
37. [Diabetes mellitus and skin diseases. 2. Skin disorders being observed in theprimary and secondary diabetes]. Inoue S; Haraguchi Y; Sato T Iryo; 1970 Dec; 24(2):985-1000. PubMed ID: 4250343 [No Abstract] [Full Text] [Related]
38. Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream. Gorman CR; White SW Arch Dermatol; 2005 Sep; 141(9):1168. PubMed ID: 16172323 [No Abstract] [Full Text] [Related]